On Nov. 29th, the 2023 MIT Technology Review China Future Health Entrepreneurship Competition Finals and Future Health Forum were successfully held in Hangzhou Future Science and Technology City. The "China Digital Health Companies List 2023" was released, and RoboCT was selected into the list.

This forum analyzed the current technologies in the field of life and health from multiple perspectives such as scientific research, business, and industry through exciting road shows of innovative projects, the major release of corporate maps, and in-depth sharing and discussions from top scientists, clinical experts, and business leaders, which provides valuable guidance for future development.

In recent years, emerging digital technologies represented by artificial intelligence, big data, cloud computing, the Internet of Things, and 5G have developed rapidly and have been deeply integrated with multiple industries. Digital health, as the product of the integration of digital technology and medical care, is bringing revolutionary changes to the medical field. It not only changes the way and quality of medical services, but also provides new opportunities for medical research and innovation.

As one of the important links of the Future Health Forum, the release of the "Second China Digital Medical Technology Innovation Enterprise List" aims to sort out and display the overall strength and development trend of China's digital medical technology innovation enterprises. In the field of medical robots, RoboCT has been selected with its unique technical advantages and rich application scenarios. This is not only an affirmation of RoboCT's digital innovation, but also its important role in promoting the digital transformation of the medical industry.

In the future, RoboCT will continue to delve deeply into the innovative R&D of digital healthcare, actively expand partnerships, strengthen exchanges and cooperation with all parties, and help promote the development of digitalization by deeply exploring the potentialness.